Immunovant, Inc. ($IMVT)
Filing Information
| Accession Number | 0001764013-26-000081 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 10, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
3,487
Total Value
$137,924.83
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Technology Officer | Common Stock | โ | Jul 8, 2026 | Sale | 1,906 | $39.53 | $75,344.18 | 209,779 | Direct | โ | View Details | |
Chief Technology Officer | Common Stock | โ | Jul 8, 2026 | Sale | 105 | $39.99 | $4,198.95 | 209,674 | Direct | โ | View Details | |
Chief Technology Officer | Common Stock | โ | Jul 8, 2026 | Sale | 1,399 | $39.53 | $55,302.47 | 208,275 | Direct | โ | View Details | |
Chief Technology Officer | Common Stock | โ | Jul 8, 2026 | Sale | 77 | $39.99 | $3,079.23 | 208,198 | Direct | โ | View Details |